Companies unite to bolster diagnostics for cancer and liver disease
Two companies set on making improvements for those with lung cancer, non-alcoholic fatty liver disease…
28/06/2022 - 2 minutes
Two companies set on making improvements for those with lung cancer, non-alcoholic fatty liver disease…
A cancer drug from AstraZeneca and Daiichi Sankyo called Enhertu, that reduces the risk of…
Data supporting the detection of minimal residual disease (MRD) has highlighted potential to provide an…